No cure for…..

Before we get into our commentary let’s get the numbers out of the way as Tandem (NASDAQ: TNDM) released their amended S-1 which contained the following information. The company hopes to raise $46 million by issuing and we would recommend sitting down before you continue reading almost 13.5 million shares. Which lead the company to state “Investors purchasing in this offering will incur immediate and substantial dilution” which is the most truthful sentence in the S-1.

Now it does no use to state that anyone who invests in Tandem at this point either enjoys . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

This entry was posted in Email Alerts. Bookmark the permalink.